Brief: Acura Pharmaceuticals Received $250,000 Loan From AD Pharma For Operations Through End Of April 2023
20/03/2023 16:17
March 20 (Reuters) - Acura Pharmaceuticals Inc
ACUR.PK :
* ACURA PHARMACEUTICALS INC - RECEIVED A $250,000 LOAN FROM
AD
PHARMA; FUNDING GIVEN BY AD PHARMA WILL BE USED FOR OPERATIONS
THROUGH END OF APRIL 2023
* ACURA PHARMACEUTICALS INC - IN ABSENCE OF ADDITIONAL
FINANCING
BY END OF APRIL, WILL BE REQUIRED TO SCALE BACK/ TERMINATE
OPERATIONS
* ACURA PHARMACEUTICALS INC - IN ABSENCE OF ADDITIONAL
FINANCING
BY END OF APRIL, MAY BE REQUIRED TO SEEK PROTECTION UNDER
APPLICABLE BANKRUPTCY LAWS
Further company coverage: ACUR.PK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Acura Pharmaceuticals
See all newsBrief: Acura Pharmaceuticals Received A $250,000 Loan From Abuse Deterrent Pharma, LLC on October 11
Brief: Acura Pharmaceuticals Inc Receives $200,000 Loan From Abuse Deterrent Pharma
Brief: Acura Pharmaceuticals Received $250,000 Loan From AD Pharma For Operations Through End Of April 2023
Brief: Acura Pharmaceuticals, AD Pharma Amend License to LIMITx LTX-03
Insight: Novavax bosses cash out for $46 mln with COVID-19 vaccine trials still under way